Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.33)
# 2,641
Out of 5,012 analysts
25
Total ratings
50%
Success rate
10.82%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $32.01 | +71.82% | 1 | Sep 3, 2025 | |
| BWAY BrainsWay | Maintains: Outperform | $15 → $19 | $15.37 | +23.66% | 4 | Aug 14, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $26.30 | +17.87% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.78 | +161.51% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $2.38 | +152.10% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $1.59 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $19.27 | +29.74% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $4.37 | +5,391.99% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $22.55 | +254.77% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $7.26 | +216.80% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $3.09 | +676.70% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.36 | +84,645.76% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.32 | - | 1 | Sep 27, 2017 |
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $32.01
Upside: +71.82%
BrainsWay
Aug 14, 2025
Maintains: Outperform
Price Target: $15 → $19
Current: $15.37
Upside: +23.66%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $26.30
Upside: +17.87%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.78
Upside: +161.51%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $2.38
Upside: +152.10%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $1.59
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $19.27
Upside: +29.74%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $4.37
Upside: +5,391.99%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $22.55
Upside: +254.77%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $7.26
Upside: +216.80%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $3.09
Upside: +676.70%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.36
Upside: +84,645.76%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.32
Upside: -